Events

translation missing: en.activerecord.attributes.event.titles.recall_field_safety_notice

According to Saudi Food & Drug Authority, this translation missing: en.activerecord.attributes.event.types.recall_field_safety_notice involved a device in Saudi Arabia that was produced by Medtronic SA.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Recall / Field Safety Notice
  • Event ID
    mdprc 011 03 17 000
  • Event Initiated Date
    2017-03-02
  • Event Country
    Saudi Arabia
  • Event Source
    SFDA
  • Event Source URL
    https://ncmdr.sfda.gov.sa/Secure/CA/CaViewRecall.aspx?caid=4&rid=10743
  • Notes / Alerts
    Saudi data is current through January 2019. All of the data comes from the Saudi Food & Drug Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Saudi Arabia.
  • Extra notes in the data
    Report Source: NCMDR
    SFDA urges all hospitals that have devices subjected to recall, to contact the company.
  • Reason
    This specific subset of stent grafts has greater susceptibility to fabric permeability variations that may be associated with endoleaks observed during the initial implant procedure. at the time of implant procedure this permeability variation may cause the physician to categorize a type iv endoleak (which typically self-resolves over time) as an acute type iii fabric endoleak because the leak may appear to be focal or a localized leak as opposed to a diffused leak (blush). the misclassification as an acute type iii fabric endoleak may lead to unnecessary secondary interventions.

Device

Endurant™ / Endurant II ™ 23mm and 25mm Bifurcated Stent Graft Systems
  • Model / Serial
    Affected Endurant / Endurant II Model Numbers: ENBF2313C120EE, ETBF2313C166EE, ENBF2313C145EE, ETBF2316C124EE, ENBF2313C170EE, ETBF2316C145EE, ENBF2316C145EE, ETBF2316C166E, ENBF2316C170EE, ETBF2316C166EE, ENBF2513C145EE, ETBF2513C124EE, ENBF2513C170EE, ETBF2513C145EE, ENBF2516C145EE, ETBF2513C166EE, ENBF2516C170EE, ETBF2516C124EE, ETBF2313C124E, ETBF2516C145E, ETBF2313C124EE, ETBF2516C145EE, ETBF2313C145EE, ETBF2516C166E, ETBF2313C166E, ETBF2516C166EE Note: Only specific serial numbers are affected, please use the website link provided in the attached FSN to determine whether a serial number is affected or not.
  • Product Description
    Stent Graft
  • Manufacturer
    Medtronic SA

Manufacturer

Medtronic SA
  • Manufacturer Parent Company (2017)
    Medtronic plc
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Manufacturers representative
    Medtronic Saudi Arabia
  • Source
    SFDA